Allison Dorval, CFO: Verve Therapeutics VERV Sell · Filed 23/12/01

Trade details

Type: Insider sale
Amount: $6,343.3
Shares · price: 554 sh · $11.45 a share
Held after: 4,060 sh
Stock: Verve Therapeutics VERV
Person: Allison DorvalCFO
Trade date: 23/11/29
Filed: 23/12/01
Days to filing: 2 days

Sold 12.0% of holdings

Share of holding sold: 12.0%

Verve Therapeutics trades, last 26 weeks

What else happened in Verve Therapeutics around then

Filed or reported within 30 days of the trade day · 23/10/30~23/12/29

Allison Dorval's recent trades

Allison DorvalDirector
Sell10b5-1 planPuma Biotechnology
Sell10b5-1 plan
Puma Biotechnology
PBYI
$83.6K
11,610 sh
$83.6K
Filed 06/15
Traded 06/12
Allison DorvalDirector
Planned sale10b5-1 planPuma Biotechnology
Planned sale10b5-1 plan
Puma Biotechnology
PBYI
$84.3K
11,610 sh
$84.3K
Filed 06/12
Traded 06/12
Allison DorvalDirector
Sell10b5-1 planPuma Biotechnology
Sell10b5-1 plan
Puma Biotechnology
PBYI
$39.5K
11,610 sh
$39.5K
Filed 25/06/17
Traded 25/06/13
Allison DorvalDirector
Planned sale10b5-1 planPuma Biotechnology
Planned sale10b5-1 plan
Puma Biotechnology
PBYI
$39.4K
11,610 sh
$39.4K
Filed 25/06/13
Traded 25/06/13
Allison DorvalCFO
Sell10b5-1 planVerve Therapeutics
Sell10b5-1 plan
Verve Therapeutics
VERV
$13.9K
3,350 sh
$13.9K
Filed 25/04/03
Traded 25/04/02